We found that in addition to trolox (Figure 4D), rotenone and MitoQ diminished the olaparib-induced anti-tumor activity of macrophages (Figure 4J), consistent with ROS as a result of RET causing olaparib-induced reprogramming of macrophages (Figure 4K). The gene discussed is RET; the disease is neoplasm.